Search research articles
Contact Us
Filters
Showing results (11-20 of 432) with videos related to
Page
of 44
Sort By:
Science (New York, N.Y.)
|
June 2, 2012
Medicine. Whole-genome sequencing: the new standard of care?
Liam R Brunham, Michael R Hayden
Nature Clinical Practice. Neurology
|
September 23, 2006
Is tetrabenazine safe and effective for suppressing chorea in Huntington's disease?
Blair R Leavitt, Michael R Hayden
Nature Reviews. Neurology
|
September 7, 2011
Cholesterol metabolism in Huntington disease
Joanna M Karasinska, Michael R Hayden
Progress in Lipid Research
|
January 21, 2015
Human genetics of HDL: Insight into particle metabolism and function
Liam R Brunham, Michael R Hayden
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 5, 2010
BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice
Yuxiang Xie, Michael R Hayden, Baoji Xu
Biochemical Society Transactions
|
April 8, 2015
Post-translational myristoylation at the cross roads of cell death, autophagy and neurodegeneration
Dale D O Martin, Michael R Hayden
Nature
|
April 27, 2017
Neurodegeneration: Role of repeats in protein clearance
Dale D O Martin, Michael R Hayden
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|
February 12, 2011
Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease
Dagmar E Ehrnhoefer, Liza Sutton, Michael R Hayden
Handbook of Clinical Neurology
|
September 27, 2017
Epidemiology of Huntington disease
Chris Kay, Michael R Hayden, Blair R Leavitt
European Journal of Human Genetics : EJHG
|
July 12, 2012
When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada
Alice K Hawkins, Susan Creighton, Michael R Hayden
Page
of 44
Search research articles
Search
Showing results (11-20 of 432) with videos related to
Sort By:
Page
of 44
Science (New York, N.Y.)
|
June 2, 2012
Medicine. Whole-genome sequencing: the new standard of care?
Liam R Brunham, Michael R Hayden
Nature Clinical Practice. Neurology
|
September 23, 2006
Is tetrabenazine safe and effective for suppressing chorea in Huntington's disease?
Blair R Leavitt, Michael R Hayden
Nature Reviews. Neurology
|
September 7, 2011
Cholesterol metabolism in Huntington disease
Joanna M Karasinska, Michael R Hayden
Progress in Lipid Research
|
January 21, 2015
Human genetics of HDL: Insight into particle metabolism and function
Liam R Brunham, Michael R Hayden
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 5, 2010
BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice
Yuxiang Xie, Michael R Hayden, Baoji Xu
Biochemical Society Transactions
|
April 8, 2015
Post-translational myristoylation at the cross roads of cell death, autophagy and neurodegeneration
Dale D O Martin, Michael R Hayden
Nature
|
April 27, 2017
Neurodegeneration: Role of repeats in protein clearance
Dale D O Martin, Michael R Hayden
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|
February 12, 2011
Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease
Dagmar E Ehrnhoefer, Liza Sutton, Michael R Hayden
Handbook of Clinical Neurology
|
September 27, 2017
Epidemiology of Huntington disease
Chris Kay, Michael R Hayden, Blair R Leavitt
European Journal of Human Genetics : EJHG
|
July 12, 2012
When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada
Alice K Hawkins, Susan Creighton, Michael R Hayden
Page
of 44